BD: BDX Stock Declines Following Class I Classification for Alaris Recall
BD's recall of Alaris infusion pumps following software issues has been classified as the most severe recall by the FDA. A suspension of sales may hurt the top line going forward.
Read full article »
BD is a New Jersey-based manufacturer and supplier of medical devices, laboratory instruments and reagents for hospitals and clinical labs.
Read more